Gibson Christopher (CIK 0001856369)

Latest company ownership

Shares held
5,797,173
Last filed at
Dec 5, 2025
Confidence Score
2.5
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 19, 2025 Dec 19, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 37.5 -40,000 -4.19% $180K
Dec 4, 2025 Dec 5, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 32.5 -60,000 -6.16% $185.2K
Nov 17, 2025 Nov 19, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -80,390 -4.21% $333.6K
Nov 4, 2025 Nov 6, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 32.5 -60,000 -5.92% $208.4K
Oct 23, 2025 Oct 24, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 26.3 -100,000 -9.49% $570K
Oct 10, 2025 Oct 10, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 22.5 -120,000 -11.17% $604K
Sep 25, 2025 Sep 26, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 26.3 -100,000 -9.49% $476K
Sep 10, 2025 Sep 12, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 22.5 -120,000 -11.17% $471K
Aug 26, 2025 Aug 28, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 26.3 -100,000 -9.49% $484K
Aug 15, 2025 Aug 19, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -40,390 -4.06% $227.8K
Aug 11, 2025 Aug 13, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 5.0 -628,175 -38.71% $3.3M
May 15, 2025 May 19, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -36,197 -3.24% $153.8K
Mar 27, 2025 Mar 28, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 22.5 -138,574 -11.03% $837K
Mar 5, 2025 Mar 7, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -40,000 -1.57% $259K
Feb 18, 2025 Feb 20, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -17,132 -1.35% $182.3K
Feb 5, 2025 Feb 7, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -40,000 -1.55% $316K
Feb 3, 2025 Feb 5, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 91.3 +536,523 72.83% $40.4K
Jan 8, 2025 Jan 13, 2025 RECURSION PHARMACEUTICALS, INC. CEO Sell 38.8 -40,000 -2.64% $287.2K
Dec 4, 2024 Dec 6, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 38.8 -40,000 -2.64% $285.6K
Nov 15, 2024 Nov 19, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -26,023 -3.41% $160.7K
Nov 13, 2024 Nov 15, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 38.8 -40,000 -2.56% $301.8K
Oct 2, 2024 Oct 4, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 41.3 -40,000 -2.56% $244.8K
Sep 4, 2024 Sep 6, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 41.3 -40,000 -2.56% $243.6K
Aug 15, 2024 Aug 19, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -26,082 -3.44% $174.5K
Aug 7, 2024 Aug 9, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -50,000 -3.19% $343K
Jul 10, 2024 Jul 12, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -125,000 -5.21% $747.5K
Jun 5, 2024 Jun 7, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 22.5 -125,000 -14.99% $871K
May 15, 2024 May 17, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 40.0 -26,082 -3.12% $261.1K
May 1, 2024 May 3, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -125,000 -3.50% $810K
Apr 3, 2024 Apr 5, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 20.0 -155,000 -14.17% $1.2M
Mar 28, 2024 Apr 1, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 26.3 -90,000 -7.94% $656.5K
Mar 6, 2024 Mar 8, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -71,319 -3.12% $719.5K
Feb 15, 2024 Feb 16, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 45.0 -11,148 -1.00% $138.6K
Feb 9, 2024 Feb 13, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 91.3 +341,364 44.06% $32.6K
Feb 7, 2024 Feb 9, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -58,272 -3.59% $445K
Jan 3, 2024 Jan 5, 2024 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -65,853 -3.99% $530.6K
Dec 6, 2023 Dec 8, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -69,829 -4.15% $448.4K
Nov 10, 2023 Nov 17, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 37.5 -26,913 -3.18% $121.4K
Nov 1, 2023 Nov 3, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -62,177 -6.92% $321.3K
Oct 4, 2023 Oct 6, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -59,794 -6.63% $431K
Sep 6, 2023 Sep 8, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -58,765 -6.32% $517.4K
Aug 15, 2023 Aug 17, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -16,913 -1.90% $155.4K
Aug 2, 2023 Aug 4, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -65,015 -6.80% $847.7K
Jul 12, 2023 Jul 14, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -56,818 -5.84% $712.2K
Jun 7, 2023 Jun 9, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -56,436 -5.80% $510.8K
May 15, 2023 May 17, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -11,661 -1.22% $65.3K
Jan 5, 2023 May 5, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -77,073 -1.32% $278.3K
Apr 25, 2022 Apr 28, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 45.0 -75,500 -1.16% $136.7K
Apr 5, 2023 Apr 7, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 38.8 -63,327 -2.23% $351.7K
Mar 8, 2023 Mar 10, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 22.5 -120,890 -11.41% $892.9K
Mar 2, 2023 Mar 6, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 41.3 -21,000 -2.18% $166.3K
Feb 15, 2023 Feb 17, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 51.3 -1,346 -0.14% $11.4K
Feb 1, 2023 Feb 3, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 95.0 +395,468 11.75% $205.4K
Apr 25, 2022 Jan 6, 2023 RECURSION PHARMACEUTICALS, INC. CEO Sell 45.0 -78,000 -1.29% $155.1K
Dec 1, 2022 Dec 2, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -39,710 -3.29% $358.9K
Nov 15, 2022 Nov 17, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 45.0 -5,751 -1.00% $68.2K
Nov 3, 2022 Nov 4, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -39,193 -3.29% $392.2K
Oct 6, 2022 Oct 7, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -38,553 -3.31% $446.6K
Sep 1, 2022 Sep 2, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -39,066 -3.43% $404.2K
Aug 15, 2022 Aug 17, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 42.5 -5,751 -1.06% $74.5K
Aug 4, 2022 Aug 5, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -39,325 -3.50% $373.1K
Jul 7, 2022 Jul 8, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -39,614 -3.61% $358.6K
Jun 2, 2022 Jun 6, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -42,190 -3.93% $257.6K
May 16, 2022 May 18, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 48.8 -5,764 -1.13% $32.7K
May 4, 2022 May 6, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -55,330 -3.48% $357.9K
Apr 28, 2022 May 2, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -80,675 -4.02% $495.4K
Apr 21, 2022 Apr 25, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -92,108 -4.06% $494.3K
Apr 18, 2022 Apr 20, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -38,336 -4.63% $261.8K
Apr 14, 2022 Apr 18, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 35.0 -37,017 -4.79% $279.6K
Apr 8, 2022 Apr 12, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -39,420 -5.48% $260K
Apr 7, 2022 Apr 11, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -39,218 -5.87% $256.5K
Apr 6, 2022 Apr 8, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -38,326 -6.22% $259.1K
Apr 5, 2022 Apr 7, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 30.0 -36,972 -6.59% $274.5K
Mar 11, 2022 Mar 15, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 17.5 -336,150 -32.38% $2.2M
Mar 7, 2022 Mar 9, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 17.5 -300,000 -56.18% $2.2M
Feb 22, 2022 Feb 24, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 17.5 -100,000 -29.94% $1M
Feb 4, 2022 Feb 8, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 90.0 +210,550 897.10% $3.9K
Jan 31, 2022 Feb 2, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 22.5 -19,858 -45.83% $233K
Jan 13, 2022 Jan 14, 2022 RECURSION PHARMACEUTICALS, INC. CEO Sell 17.5 -341,000 -81.15% $4.7M
Dec 16, 2021 Dec 20, 2021 RECURSION PHARMACEUTICALS, INC. CEO Sell 52.5 -200 -0.84% $4K
Dec 13, 2021 Dec 15, 2021 RECURSION PHARMACEUTICALS, INC. CEO Sell 53.8 -100 -0.42% $2K
Dec 8, 2021 Dec 10, 2021 RECURSION PHARMACEUTICALS, INC. CEO Sell 25.0 -11,750 -14.30% $236.6K
Nov 21, 2021 Dec 9, 2021 RECURSION PHARMACEUTICALS, INC. CEO Sell 47.5 -19,792 -0.21% $405.4K